VRM
CCAP icon

Vectors Research Management’s Crescent Capital BDC CCAP Stock Holding History

Vectors Research Management’s Portfolio CCAP Stock Details CCAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$8K – 198
2022
Q2 		$8K Buy
+500
New +$8.57K ﹤0.01% 389

Other funds holding CCAP

FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
C
Cliffwater Marina Del Rey, California $377M AUM 5.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vectors Research Management's CCAP Position: Q3 2022 in Review

Vectors Research Management sold out of Crescent Capital BDC (CCAP) in Q3 2022, closing a stake of 500 shares — an estimated $8K sold.

Vectors Research Management first reported a position in CCAP in Q2 2022 and held it in 1 quarter. The position peaked at $8K in Q2 2022. 47 funds tracked by Wall St. Rank hold CCAP as of Q3 2022.

  • Vectors Research Management reported no remaining Crescent Capital BDC position as of Q3 2022 after selling out during the quarter.
  • Vectors Research Management sold 500 Crescent Capital BDC shares in Q3 2022, an estimated $8K.
  • Vectors Research Management first reported a position in Crescent Capital BDC in Q2 2022 and held it in 1 quarter.
  • Vectors Research Management's Crescent Capital BDC position peaked at $8K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.